FDA Inspection 1302624 — Phoenix Childrens Hospital

Phoenix Childrens Hospital — FEI 3003605121

The FDA completed an inspection of Phoenix Childrens Hospital on February 4, 2026 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 4, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Phoenix, AZ (United States)